Marked Decreased Tracer Binding in 123 I-FP-CIT SPECT Scans From Lisdexafetamine Dismesylate Interaction: A Case Report.
Toji MiyagawaCynthia VernonScott A PrzybelskiHoon-Ki MinJulie A FieldsKejal KantarciVal LoweBradley F Boeve
Published in: Clinical neuropharmacology (2024)
This case suggests that lisdexafetamine dimesylate may have a strong interference with 123 I-FP-CIT SPECT, decreasing the tracer binding to the dopamine transporter and presenting false positive results.